• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动神经元病的专科转诊和诊断延迟:描绘患者在医疗保健中经历的层层障碍。

Specialist referrals and diagnostic delays in motor neurone disease: Mapping patients' journey through hoops and hurdles in healthcare.

机构信息

Department of Neurology, Lancashire Teaching Hospitals NHS Foundation Trust, PR2 9HT, United Kingdom.

Department of Neurology, Lancashire Teaching Hospitals NHS Foundation Trust, PR2 9HT, United Kingdom; University of Central Lancashire, Preston, PR1 2HE, United Kingdom.

出版信息

Clin Med (Lond). 2024 Jul;24(4):100228. doi: 10.1016/j.clinme.2024.100228. Epub 2024 Jul 14.

DOI:10.1016/j.clinme.2024.100228
PMID:39002949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11345289/
Abstract

Motor neuron disease (MND) is an uncommon but invariably fatal condition, with a median survival of 24-48 months from symptom onset. Although there is no cure at the moment, early diagnosis is crucial to enable timely access to multidisciplinary care, and enrolment in clinical trials utilising investigational therapies. Unfortunately, diagnostic delays remain common, and the average delay between symptom onset and diagnosis is 12 months. Large numbers of specialist referrals have been suggested as a key contributor to diagnostic delays. We conducted a retrospective review of the medical records of patients diagnosed with MND in Lancashire and South Cumbria, to investigate whether large numbers of specialty referrals are a common occurrence in MND. Our review identified that 35% of patients with MND were seen by two or more specialties before being referred to neurology. This rose to 49% when patients with bulbar onset disease were considered. 9% of cases saw three or more specialists. There was a statistically significant correlation between the number of specialist referrals and delays in neurology referral. We hope our findings will increase awareness of the importance of early neurology referral in the diagnosis of MND and promote the use of the MND Red Flag tool as a means of identifying patients in need of prompt neurological evaluation.

摘要

运动神经元病(MND)是一种罕见但致命的疾病,从症状出现到中位生存期为 24-48 个月。虽然目前尚无治愈方法,但早期诊断对于及时获得多学科治疗和参与使用试验性治疗的临床试验至关重要。不幸的是,诊断延迟仍然很常见,从症状出现到诊断的平均时间为 12 个月。大量专家转诊被认为是导致诊断延迟的一个主要因素。我们对兰开夏郡和南坎布里亚地区被诊断为 MND 的患者的病历进行了回顾性审查,以调查 MND 患者是否经常出现大量专科转诊的情况。我们的审查发现,35%的 MND 患者在被转介到神经内科之前曾看过两个或更多专科。当考虑到延髓发病的患者时,这一比例上升到 49%。9%的病例看了三个或更多的专科。神经内科转诊的数量与转诊延迟之间存在统计学显著相关性。我们希望我们的发现将提高对早期神经内科转诊在 MND 诊断中的重要性的认识,并促进使用 MND 红旗工具作为识别需要及时神经评估的患者的手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/7f053b085b8c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/6294a862de4b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/5836e64dafb6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/511546159cee/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/b5ee3e1d0f6a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/7f053b085b8c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/6294a862de4b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/5836e64dafb6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/511546159cee/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/b5ee3e1d0f6a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3495/11345289/7f053b085b8c/gr5.jpg

相似文献

1
Specialist referrals and diagnostic delays in motor neurone disease: Mapping patients' journey through hoops and hurdles in healthcare.运动神经元病的专科转诊和诊断延迟:描绘患者在医疗保健中经历的层层障碍。
Clin Med (Lond). 2024 Jul;24(4):100228. doi: 10.1016/j.clinme.2024.100228. Epub 2024 Jul 14.
2
Decision-making and referral processes for patients with motor neurone disease: a qualitative study of GP experiences and evaluation of a new decision-support tool.运动神经元病患者的决策与转诊流程:对全科医生经验的质性研究及一种新决策支持工具的评估
BMC Health Serv Res. 2017 May 8;17(1):339. doi: 10.1186/s12913-017-2286-0.
3
When months matter; modelling the impact of the COVID-19 pandemic on the diagnostic pathway of Motor Neurone Disease (MND).当时间至关重要时;模拟 COVID-19 大流行对肌萎缩侧索硬化症(MND)诊断途径的影响。
PLoS One. 2023 Jan 27;18(1):e0259487. doi: 10.1371/journal.pone.0259487. eCollection 2023.
4
Timeliness of diagnosis in motor neurone disease: a population-based study.运动神经元病的诊断及时性:一项基于人群的研究。
Ulster Med J. 2008 Jan;77(1):18-21.
5
Motor neurone disease in Lancashire and South Cumbria in North West England and an 8 year experience with enteral nutrition.英格兰西北部兰开夏郡和南坎布里亚郡的运动神经元病及8年肠内营养经验
J Clin Neurosci. 2016 Feb;24:47-51. doi: 10.1016/j.jocn.2015.07.007. Epub 2015 Oct 27.
6
Factors contributing to delays in the diagnosis of motor neuron disease - A South Australian study.导致运动神经元病诊断延误的因素——一项南澳大利亚研究。
J Neurol Sci. 2019 Dec 15;407:116540. doi: 10.1016/j.jns.2019.116540. Epub 2019 Oct 18.
7
Identifying key signs of motor neurone disease in primary care: a nested case-control study using the QResearch database.在初级保健中识别运动神经元病的关键体征:使用 QResearch 数据库进行的嵌套病例对照研究。
BMJ Open. 2022 Jun 28;12(6):e058383. doi: 10.1136/bmjopen-2021-058383.
8
GPs have key role in managing motor neurone disease.全科医生在运动神经元病的管理中发挥着关键作用。
Practitioner. 2011 Sep;255(1743):19-22, 2.
9
Prevalence and factors associated with advanced care directives in a motor neuron disease multidisciplinary clinic in Australia.澳大利亚运动神经元疾病多学科诊所中高级医疗指示的流行情况及相关因素。
Postgrad Med J. 2021 Sep;97(1151):566-570. doi: 10.1136/postgradmedj-2020-138184. Epub 2020 Aug 11.
10
DSP-01 Barriers to the diagnosis of motor neuron disease - a South Australian study.DSP - 01运动神经元病诊断的障碍——一项南澳大利亚的研究。
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):289-300. doi: 10.1080/21678421.2019.1646998.

引用本文的文献

1
Banking on My Voice: Life with Motor Neurone Disease.依靠我的声音:与运动神经元病相伴的生活
Healthcare (Basel). 2025 Jul 21;13(14):1770. doi: 10.3390/healthcare13141770.
2
Never forget the basics while seeking correct diagnosis and management.在寻求正确诊断和治疗时,切勿忘记基本原则。
Clin Med (Lond). 2024 Jul;24(4):100232. doi: 10.1016/j.clinme.2024.100232.

本文引用的文献

1
Diagnostic delay in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的诊断延迟。
Eur J Neurol. 2023 Sep;30(9):2595-2601. doi: 10.1111/ene.15874. Epub 2023 May 30.
2
Trial of Antisense Oligonucleotide Tofersen for ALS.针对肌萎缩侧索硬化症的反义寡核苷酸药物 Tofersen 的试验。
N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705.
3
Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的诊断时间及影响诊断延迟的因素。
J Neurol Sci. 2020 Oct 15;417:117054. doi: 10.1016/j.jns.2020.117054. Epub 2020 Jul 24.
4
Factors contributing to delays in the diagnosis of motor neuron disease - A South Australian study.导致运动神经元病诊断延误的因素——一项南澳大利亚研究。
J Neurol Sci. 2019 Dec 15;407:116540. doi: 10.1016/j.jns.2019.116540. Epub 2019 Oct 18.
5
Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.全球肌萎缩侧索硬化症的流行病学:已发表文献的系统评价。
Neuroepidemiology. 2013;41(2):118-30. doi: 10.1159/000351153. Epub 2013 Jul 11.
6
Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis.家族性肌萎缩侧索硬化症的发病率:系统评价和荟萃分析。
J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):623-7. doi: 10.1136/jnnp.2010.224501. Epub 2010 Nov 3.
7
Diagnosis and management of motor neurone disease.运动神经元病的诊断与管理
BMJ. 2008 Mar 22;336(7645):658-62. doi: 10.1136/bmj.39493.511759.BE.
8
Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities.肌萎缩侧索硬化三级中心对治疗结果及医院设施使用的积极影响。
J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):948-50. doi: 10.1136/jnnp.2005.083402. Epub 2006 Apr 13.
9
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.无创通气对肌萎缩侧索硬化症患者生存率和生活质量的影响:一项随机对照试验。
Lancet Neurol. 2006 Feb;5(2):140-7. doi: 10.1016/S1474-4422(05)70326-4.
10
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.利鲁唑治疗肌萎缩侧索硬化的剂量范围研究。肌萎缩侧索硬化/利鲁唑研究组II。
Lancet. 1996 May 25;347(9013):1425-31. doi: 10.1016/s0140-6736(96)91680-3.